Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders-Reference-Cited by-同舟云学术

Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders

Published:2010-06 Issue:2 Volume:199 Page:110-120
ISSN:0165-4608
Container-title:Cancer Genetics and Cytogenetics
language:en
Short-container-title:Cancer Genetics and Cytogenetics

Author:

Canestraro Martina,Galimberti Sara,Savli Hakan,Palumbo Giuseppe Alberto,Tibullo Daniele,Nagy Balint,Guerrini Francesca,Piaggi Simona,Cine Naci,Metelli Maria Rita,Petrini Mario

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Molecular Biology

Reference47 articles.

1. Arsenic trioxide: an anti cancer missile with multiple warheads;Gazitt;Hematology,2005

2. United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia;Soignet;J Clin Oncol,2001

3. Arsenic trioxide sensitizes promonocytic leukemia cells to TNFalpha-induced apoptosis via p38-MAPK-regulated activation of both receptor-mediated and mitochondrial pathways;Amrán;Biochim Biophys Acta,2007

4. Arsenic induces apoptosis of multidrug-resistant human myeloid leukemia cells that express Bcr-Abl or overexpress MDR, MRP, Bcl-2, or Bcl-x(L);Perkins;Blood,2000

5. Clinical activity of arsenic trioxide for the treatment of multiple myeloma;Munshi;Leukemia,2002

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An overview of arsenic trioxide-involved combined treatment algorithms for leukemia: basic concepts and clinical implications;Cell Death Discovery;2023-07-27

2. Pharmacology differences among proteasome inhibitors: Implications for their use in clinical practice;Pharmacological Research;2021-05

3. The Role of Inflammation and Inflammasome in Myeloproliferative Disease;Journal of Clinical Medicine;2020-07-22

4. Inhibition of TLR4 Signaling Affects Mitochondrial Fitness and Overcomes Bortezomib Resistance in Myeloma Plasma Cells;Cancers;2020-07-22

5. The Role of CARD9 in Metabolic Diseases;Current Medical Science;2020-04